TAP SUB-STUDY - The BEACON Study (BrEAst Cancer Outcomes with NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus Treatment of Physicians Choice (TPC) in Patients with
|Effective start/end date||4/1/13 → 6/30/15|
- NEKTAR THERAPEUTICS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.